| |
| |
|
| Insider
Information: |
Meek David D. |
| Relationship: |
|
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
174,742 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,955,218 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
174,742 |
|
|
| Total
Value |
$8,955,218 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -113.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
Chief Commercial Officer |
2014-02-06 |
7,500 |
2013-09-12 |
0 |
Premium* |
|
|
Baxalta Inc |
BXLT |
EVP and President, Onc... |
2016-06-03 |
0 |
2015-07-01 |
0 |
Premium* |
|
|
uniQure B.V. |
QURE |
Director |
2023-02-27 |
16,071 |
2019-01-25 |
0 |
Premium* |
|
|
Entasis Therapeutics Holdings Inc. |
ETTX |
Director |
2022-07-11 |
0 |
2021-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
151,171 |
2022-01-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
